palbociclib
pfizer,medsir
['palbociclib', 'palmira', 'breast', 'palbo']
medsir's dr. antonio llombart-cussac presented the results of the palmira trial at #asco23. it found no progression-free survival benefit with palbociclib maintenance after a first-line regimen in hr+/her2- advanced breast cancer patients. 
Bring your idea to life💡Creating successful IITs & optimal drug development📊Medica Scientia Innovation Research🇪🇸🇺🇸https://t.co/TnOtdKHgxy…